Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
November 2011
Features
Continuous-Infusion Antipseudomonal Beta-Lactam Therapy in Patients With Cystic Fibrosis
Continuous infusions of ceftazidime for pulmonary exacerbations were found to be safe and effective, with the potential to reduce the costs of therapy, enhance patients’ quality of life, and eradicate resistant isolates of Pseudomonas aeruginosa.
William A. Prescott, Jr., PharmD; Allison E. Gentile, PharmD; Jerod L. Nagel, PharmD; and Rebecca S. Pettit, PharmD, MBA, BCPS
The Drug Shortage Crisis in the United States
Causes, Impact, and Management Strategies
The U.S. is experiencing a severe shortage of drugs, especially intravenous cancer medications. The author reviews the causes of these shortages; the effects on physicians, hospitals, and patients; the FDA’s role in managing the shortages; and strategies for alleviating the crisis.
C. Lee Ventola, MS
Partnership for Patients Presents Funding Opportunities for Hospital Pharmacists
$1 Billion Is Available to Fight Medical Errors and Reduce Readmissions
Two programs are expected to offer $1 billion in grants over a period of 5 years to hospitals and community partners in an effort to reduce patient readmissions and errors in facilities—if funds are not cut.
Stephen Barlas
Meeting Highlights
American Academy of Dermatology, Summer Academy Meeting
Patients with psoriasis and nail psoriasis can often benefit from therapies that may include biologic agents, phototherapy, and vitamin D.
Takaharu Kato and Peter Sonnenreich, MA
Departments
Medication Errors
Changes in Routines Often Increase the Risk of Mishaps
Changes in routines often raise the potential for mistakes.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Hospital Group Wants to Expand Section 340B Drug Purchase Program
The American Hospital Association would like to expand the Section 340B drug purchase program as a way to stretch its limited resources.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
FDA approvals, drug indications, and updates
Pharmaceutical Approval Update
Crizotinib (Xalkori) for lung cancer; tapendatol (Nucynta) extended-release tablets for moderate-to-severe pain; and eculizumab (Soliris) for atypical hemolytic uremic syndrome
Marvin M. Goldenberg, PhD, RPh, MS
